INTEGRATED BIOPHARMA INC Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
INTEGRATED BIOPHARMA INC (INBP) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $3.12 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-05-08
- INTEGRATED BIOPHARMA INC right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-06-30 was -$1.00K.
- INTEGRATED BIOPHARMA INC right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-03-31 was $10.00K.
- INTEGRATED BIOPHARMA INC right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-12-31 was $0.00.
- INTEGRATED BIOPHARMA INC right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- INTEGRATED BIOPHARMA INC right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $9.00K, a 86.96% decline from fiscal 2024.
- INTEGRATED BIOPHARMA INC right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $69.00K, a 95.58% decline from fiscal 2023.
- INTEGRATED BIOPHARMA INC right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $1.56M.
- INTEGRATED BIOPHARMA INC right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $3.12M 10-Q · filed 2026-05-08 | ||||
| 2025-06-30 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $9.00K derived: sum of 2 quarters · filed 2026-05-08 | $9.00K derived: sum of 3 quarters · filed 2026-05-08 | $9.00K 10-K · filed 2025-09-23 | |
| 2025-03-31 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $10.00K derived: sum of 2 quarters · filed 2026-05-08 | $10.00K 10-Q · filed 2026-05-08 | $10.00K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | $0.00 10-Q · filed 2025-02-13 | $0.00 derived: sum of 3 quarters · filed 2025-09-23 | $0.00 derived: sum of 4 quarters · filed 2025-09-23 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-09-23 | $0.00 derived: sum of 3 quarters · filed 2025-09-23 | $0.00 derived: sum of 4 quarters · filed 2025-09-23 | |
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $0.00 derived: sum of 2 quarters · filed 2025-09-23 | $0.00 derived: sum of 3 quarters · filed 2025-09-23 | $69.00K 10-K · filed 2025-09-23 | $60.00K 10-K · filed 2024-09-20 |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-05-14 | $69.00K 10-Q · filed 2025-05-14 | ||
| 2023-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | $69.00K 10-Q · filed 2025-02-13 | |||
| 2023-09-30 | $69.00K 10-Q · filed 2024-11-13 | ||||
| 2023-06-30 | $1.56M 10-K · filed 2024-09-20 | ||||
| 2022-06-30 | $0.00 10-K · filed 2023-09-15 | ||||
| 2021-06-30 | $30.00K 10-K · filed 2022-09-13 |